AKIRIN2 and ischemic stroke: tDCS treatment enhances the neuroprotective effects of ISO preconditioning on ischemic stroke by inhibiting oxidative stress and activating Akirin2‐PTEN signaling pathway, highlighting potential of combination therapy in ischemic stroke.